Skip to main content
N

Natinlab

This biotech company develops therapeutic protease treatments for neurodegenerative diseases. They use AI-powered drug discovery to identify and develop novel protease inhibitors with improved potency, selectivity, and safety profiles.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • This biotech company develops therapeutic protease treatments for neurodegenerative diseases. They use AI-powered drug discovery to identify and develop novel protease inhibitors with improved potency, selectivity, and safety profiles.
This profile is AI-generated and may contain inaccuracies.